| 3OKH: reference: Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes., Richter HG, Benson GM, Blum D, Chaput E, Feng S, Gardes C, Grether U, Hartman P, Kuhn B, Martin RE, Plancher JM, Rudolph MG, Schuler F, Taylor S, Bleicher KH, Bioorg Med Chem Lett. 2011 Jan 1;21(1):191-4. Epub 2010 Nov 12. PMID: 21134747 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).